Product Information
METFORMIN HCL ER 750 MG TABLET is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.0526 per EA under NDC 70010049201. Its NADAC has been published 382 times since Jun 12, 2019.
FDA first approved this application on Mar 16, 2018. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
750 mg/1
Manufacturer
Granules Pharmaceuticals Inc.NDC
70010049201
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209313FDA Approved
3/16/2018
TE Code
AB1
On Market Since
7/31/2018
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL ER 750 MG TABLET has been published 382 times since Jun 12, 2019, and over the history we have for it it has declined 32.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0526 per EA |
|---|---|
| All-time high | $0.0942 (Feb 10, 2021) |
| All-time low | $0.0526 (Sep 17, 2025) |
| 52-week high | $0.0566 |
| 52-week low | $0.0526 |
| Median price | $0.0637 |
| Average price | $0.0668 |
| Largest weekly change | +26.5% (Dec 23, 2020) |
| Weeks tracked | 382 |
| Tracking since | Jun 12, 2019 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Granules Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Metformin ER 750 mg market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Biguanide class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METFORMIN HCL ER 750 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL ER 750 MG TABLET, manufactured by Granules Pharmaceuticals Inc., is $0.0526 per EA (NDC 70010049201), effective Sep 30, 2026.
How has the price of METFORMIN HCL ER 750 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL ER 750 MG TABLET has declined 32.4%. It has been tracked across 382 weekly CMS publications since Jun 12, 2019.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL ER 750 MG TABLET?
Since Jun 12, 2019, the NADAC for METFORMIN HCL ER 750 MG TABLET has ranged from a low of $0.0526 (Sep 17, 2025) to a high of $0.0942 (Feb 10, 2021), with a median of $0.0637 per EA.
Are there cheaper alternatives to METFORMIN HCL ER 750 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METFORMIN HCL ER 750 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METFORMIN HCL ER 750 MG TABLET?
METFORMIN HCL ER 750 MG TABLET (NDC 70010049201) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.